Evolva has announced reaching the second technical milestone under the multi-year R&D alliance with Takasago. This achievement brings the project closer to the launch of the target ingredients and prompts a total milestone payment of USD 1 million to Evolva as well as the continuation of the collaboration into the next phases.
|Evolva Reaches Technical Milestone in Fragrance
Alliance with Takasago
Collaboration for Novel Fermentation
The aim of the collaboration is to co-develop novel fermentation routes to produce several undisclosed ingredients with broad applications in the fragrance and flavor industry. Evolva and Takasago are applying Evolva’s fermentation technology platform to develop and optimize yeast strains for the sustainable and cost-effective production of the ingredients.
Based on the timing of the progress and the contractual agreement, the revenue was recognized in Evolva’s 2016 accounts.
Evolva solves the supply chain issues of nature through a 21st century mix of biotechnology and brewing. We develop, make and sell natural ingredients that provide significant benefits to people in daily life, but whose supply chain issues have limited their use until now. Our flagship ingredients are stevia, nootkatone and resveratrol, but we work on many more, both on our own behalf and with others. To make our world sustainable requires nature and technology to work together as one, and our aim is to play a (small) part in achieving this transformation. We operate internationally.